Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

For example, people with ADHD might forget to take medications for diabetes or to make follow-up appointments with their ...

“Our findings suggest that the Adderall shortage did not cause many children to stop stimulant therapy altogether, but it did ...

The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ...

Qelbree is now the first ADHD treatment to meet the FDA's post-marketing requirement for lactation studies, following the 2019 guidance on Clinical Lactation Studies. Supernus believes that this ...

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

Small studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity disorder symptoms in kids.